Skip to main content
    I

    Imunon Inc (IMNN)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.61
    +0.02 (+2.71%)

    Market Cap: $3.85M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Imunon Inc (IMNN) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Imunon (IMNN) has a market cap of $3.85M and an enterprise value of $6.04M. Its share count is up 102.04% from a year earlier. Revenue fell 199.73% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 56.83% above the market cap, as debt exceeds cash.

    Market Cap$3.85M
    Enterprise Value$6.04M
    Latest price (Nov 17, 2026)$0.61

    Key Dates

    The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 29, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 13.66% in the quarter ended Sep 30, 2026.

    Shares Outstanding5.95M
    Shares Change (YoY)+102.04%
    Shares Change (QoQ)+13.66%

    Price Statistics

    The stock is down 85.54% over 52 weeks and trades 45.05% below its 50-day average.

    Beta (1Y)0.49
    52-Week Change-85.54%
    1-Month Change-38.06%
    3-Month Change-61.39%
    6-Month Change-72.64%
    5-Year Change-99.55%
    10-Year Change-99.97%
    Total Return (1Y)-85.54%
    Total Return (3Y CAGR)-63.40%
    Total Return (5Y CAGR)-66.66%
    Max Drawdown (1Y)-85.79%
    Max Drawdown (3Y)-98.63%
    Sharpe Ratio (1Y)-2.83
    Correlation with SPY (1Y)0.10
    50-Day Average$1.11
    200-Day Average$2.07
    52-Week Range$0.49 to $4.35
    RSI (14 Days)26.9
    Average Volume (20 Days)241.96K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.38x current liabilities, and total debt is 2.38x shareholder equity.

    Current Ratio1.38x
    Quick Ratio1.38x
    Debt / Equity2.38x

    Returns and Efficiency

    Return on invested capital is -131.55% over the last 12 months, against a 5-year average of -95.16%.

    Return on Equity (ROE)-573.39%
    Return on Assets (ROA)-125.21%
    Return on Invested Capital (ROIC)-131.55%
    Return on Capital Employed (ROCE)-189.70%
    ROIC (5Y Average)-95.16%

    Scores

    IMNN has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was -$725.20K over the last 12 months.

    Revenue-$725.20K
    Revenue Growth (YoY)-199.73%
    Gross Profit-$169.26K
    Operating Income-$14.81M
    Pretax Income-$15.04M
    Net Income-$15.04M
    EBITDA-$13.88M
    EBIT-$14.74M
    Reported EPS (TTM)-$3.32

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 21.82% of the $12.01M in total assets.

    Cash and Equivalents$4.04M
    Total Debt$6.23M
    Net Debt$2.19M
    Net Debt Per Share$0.37
    Working Capital$1.60M
    Shareholder Equity$2.62M
    Book Value Per Share$0.44
    Total Assets$12.01M
    Total Liabilities$9.39M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $74.46K of capital spending, operating cash flow left -$13.95M of free cash flow.

    Operating Cash Flow-$13.87M
    Capital Expenditures$74.46K
    Free Cash Flow-$13.95M
    FCF Per Share-$2.49
    Depreciation and Amortization$861.90K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    IMNN does not pay a dividend. Its free cash flow yield is -384.33%.

    FCF Yield-384.33%
    Buyback Yield-233.71%
    Shareholder Yield-233.71%

    Stock Splits

    The last split was a 1-for-15 reverse split on Jul 25, 2025.

    Last Split DateJul 25, 2025
    Split TypeReverse split
    Split Ratio1:15

    Peer Position

    Against 3 similar companies, IMNN has the 2nd highest ROIC.

    ROIC-131.55% vs -156.81% median
    Revenue Growth (Trailing 4 Quarters, YoY)-199.73% vs -78.57% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About IMNN

    What is IMNN's market cap?

    Imunon has a market cap of $3.85M. Its enterprise value, which adds debt and subtracts cash, is $6.04M.

    How many shares of IMNN are outstanding?

    Imunon has 5.95M shares outstanding. The count is up 102.04% from a year earlier.

    Does IMNN pay a dividend?

    No. Imunon does not pay a dividend.

    How much debt does IMNN have?

    Imunon has $6.23M of total debt and $4.04M of cash and equivalents, a net debt position of $2.19M.